These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8585543)

  • 1. Will increases in dose intensity improve outcome: pro.
    Hryniuk W
    Am J Med; 1995 Dec; 99(6A):69S-70S. PubMed ID: 8585543
    [No Abstract]   [Full Text] [Related]  

  • 2. Will increases in dose intensity improve outcome: con.
    Souhami RL
    Am J Med; 1995 Dec; 99(6A):71S-76S. PubMed ID: 8585544
    [No Abstract]   [Full Text] [Related]  

  • 3. Will increases in chemotherapy dose intensity improve outcome of patients with common malignancies?
    Tannock I
    Am J Med; 1995 Dec; 99(6A):68S-69S. PubMed ID: 8585542
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian cancer: is dose intensity dead?
    Ozols RF
    J Clin Oncol; 2007 Sep; 25(27):4157-8. PubMed ID: 17698802
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic drugs: the search for dose response.
    Dodwell DJ
    Lancet; 1993 Mar; 341(8845):614-6. PubMed ID: 8094841
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications of dose intensity for cancer clinical trials.
    Semin Oncol; 1987 Dec; 14(4 Suppl 4):1-44. PubMed ID: 3686043
    [No Abstract]   [Full Text] [Related]  

  • 7. A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity.
    Hryniuk W; Frei E; Wright FA
    J Clin Oncol; 1998 Sep; 16(9):3137-47. PubMed ID: 9738586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of hematological growth factors to enable dose intensification in chemotherapy for soft tissue sarcomas.
    Liem GS; Verweij J
    Stem Cells; 1994 Jul; 12(4):402-8. PubMed ID: 7951007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to induction therapy with adult acute myeloid leukaemia.
    Bishop JF
    Acta Haematol; 1998; 99(3):133-7. PubMed ID: 9587394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of the relationship between dose and benefit in phase I targeted agent trials.
    Gupta S; Hunsberger S; Boerner SA; Rubinstein L; Royds R; Ivy P; LoRusso P
    J Natl Cancer Inst; 2012 Dec; 104(24):1860-6. PubMed ID: 23169991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of dose intensity in the outcome of chemotherapy.
    Hryniuk WM
    Important Adv Oncol; 1988; ():121-41. PubMed ID: 3042601
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms to improve chemotherapy effectiveness.
    Young RC
    Cancer; 1990 Feb; 65(3 Suppl):815-22. PubMed ID: 2406004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning from previous responses in phase I dose-escalation studies.
    Whitehead J; Zhou Y; Stallard N; Todd S; Whitehead A
    Br J Clin Pharmacol; 2001 Jul; 52(1):1-7. PubMed ID: 11453884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Therapeutic intent" in phase 1 oncology trials: a justifiable objective.
    Markman M
    Arch Intern Med; 2006 Jul; 166(14):1446-8. PubMed ID: 16864753
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose intensity versus total dose of chemotherapy: an experimental basis.
    Skipper HE
    Important Adv Oncol; 1990; ():43-64. PubMed ID: 2182523
    [No Abstract]   [Full Text] [Related]  

  • 16. Finding the right dose for cancer therapeutics--can we do better?
    Rubin EH; Anderson KM
    Clin Cancer Res; 2010 Feb; 16(4):1085-7. PubMed ID: 20145182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Meta-analysis comparing cisplatin total dose intensity and survival: a critical reappraisal.
    Sauerbrei W; Blettner M; Schumacher M
    Gynecol Oncol; 1996 Sep; 62(3):427-9. PubMed ID: 8830743
    [No Abstract]   [Full Text] [Related]  

  • 18. Relative dose intensity: improving cancer treatment and outcomes.
    Lenhart C
    Oncol Nurs Forum; 2005 Jul; 32(4):757-64. PubMed ID: 15990905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concept of dose intensification in the treatment of neoplastic disease.
    Wandl UB; Niederle N
    Infection; 1992; 20 Suppl 2():S107-10. PubMed ID: 1493934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual variation in factors affecting the steps between dose application and effects of antineoplastic agents.
    Fuhr U; Kirchheiner J
    Int J Clin Pharmacol Ther; 2005 Dec; 43(12):573-4. PubMed ID: 16372521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.